09 Apr Trading Update
Paris, France and Camberley, UK – 9 April 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its supply contract with...
01 Apr PathFlow®: Future innovation of COVID-19 Lateral Flow Testing
PathFlow®: Future innovation of COVID-19 Lateral Flow Testing Advancing technology and a unique wealth of knowledge are the driving forces behind innovative development in our PathFlow® portfolio of diagnostic tests...
24 Mar Launch of CE-Mark test to detect multiple COVID-19 variants of concern
SNPsig® VariPLEX™ is able to detect six key mutations of SARS-CoV-2 using PCR genotyping in under two hours Paris, France and Camberley, UK – 24 March 2021 – Novacyt (EURONEXT GROWTH:...
17 Mar Launch of mobile processing laboratories to detect COVID-19
Paris, France and Camberley, UK – 17 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the expansion of its VersaLab™ service with...
15 Mar Holdings in Company
Paris, France and Camberley, UK – 15 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 15 March...
15 Mar Holdings in Company
Paris, France and Camberley, UK – 15 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 12 March...
12 Mar Holdings in Company
Paris, France and Camberley, UK – 12 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 11 March...
04 Mar Evolution of testing and sequencing during COVID-19 is vital to future pandemic control
The advances in testing and genome sequencing during the COVID-19 pandemic will be crucial to predicting and managing future pandemics, according to scientific discussion during the NovaTalk webinar on February...
24 Feb Correction: Research and Development Update
This is a correction to the Research and Development Update announcement published at 7:00am on 24 February 2021 (RNS number 1141Q) which has been amended with the following underlined additions...
24 Feb Research and Development Update
Paris, France and Camberley, UK – 24 February 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the progress of its...